Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 923-929

  Kato, Junji ^a   Kobune, Masayoshi ^a   Kohgo, Yutaka ^b   Sugawara, Naoki ^a   Hisai, Hiroyuki ^a   Nakamura, Tokiko ^a   Sakamaki, Sumio ^a   Sawada, Norimasa ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

apoptosis; hepatitis; hepatoma; iron depletion; iron overload

Indexed keywords

COPPER; FERRIC AMMONIUM CITRATE; IRON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COPPER METABOLISM; HEMOCHROMATOSIS; HEPATITIS; IRON DEFICIENCY ANEMIA; IRON STORAGE; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0029810054     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118875     Document Type: Article

References (37)

1. Di Bisceglie, A.M., C. Axiotis, J.H. Hoofnagle, and B.R. Bacon. 1992. Measurement of iron status in patients with chronic hepatitis. Gastroenterology. 102:2108-2113.
2. Lustbalder, E.D., H.W.L. Hann, and B.S. Blumberg. 1983. Serum ferritin as a predictor of host response to hepatitis B virus infection. Science (Wash. DC). 220:423-425.
3. Bassett, M.L., J.W. Halliday, and L.W. Powell. 1986. Value of hepatic iron measurement in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:24-29.
4. Fargion, S., A.L. Fracanzani, A. Piperno, M. Braga, R. D'Alba, G. Ronchi, and G. Fiorelli. 1994. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology. 20:1426-1431.
5. Hayashi, H., T. Takikawa, N. Nishimura, M. Yano, T. Isomura, and N. Sakamoto. 1994. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am. J. Gastroenterol. 89:986-988.
6. Yoshida, M.C., R. Masuda, M. Sasaki, N. Takeichi, H. Kobayashi, K. Denpo, and M. Mori. 1987. New mutation causing hereditary hepatitis in the laboratory rat. J. Hered. 78:361-365.
7. Li, Y., Y. Togashi, S. Sato, T. Emoto, J.-H. Kang, N. Takeichi, H. Kobayashi, Y. Kojima, Y. Une, and J. Uchino. 1991. Spontaneous hepatic copper accumulation in LEC rats with hereditary hepatitis: a model of Wilson's disease. J. Clin. Invest. 87:1851-1861.
8. Powell, C.J. 1994. Copper-overloaded causes cancer? The LEC rat: a model for human hepatitis, liver cancer, and much more. Hum. Exp. Toxicol. 13:910-912.
9. Schilsky, M.L. R.J. Stockert, and I. Sternlieb. 1994. Pleiotropic effect of LEC mutation: a rodent model of Wilson's disease. Am. J. Physiol. 266:G907-G913.
10. Li, Y., Y. Togashi, S. Sato, T. Emoto, J.-H. Kang, N. Takeichi, H. Kobayashi, Y. Kojima, Y. Une, and J. Uchino. 1991. Abnormal copper accumulation in non-cancerous and cancerous liver issues of LEC rats developing hereditary and spontaneous hepatoma. Jpn. J. Cancer Res. 82:490-492.
11. Muramatsu, Y., T. Yamada, M. Miura,T. Sakai, Y. Suzuki, T. Serikawa, R.E. Tanji, and K. Matsumoto. 1994. Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans cinnamon rats. Gastroenterology. 107:1189-1192.
12. Wu, J., J.R. Forbes, H.S. Chen, and D.W. Cox. 1994. The LEC rat has a deletion in the copper transporting ATPasc gene homologous to the Wilson disease gene. Nat. Genet. 7:541-545.
13. Thomas, G.R., J.R. Forbes, E.A. Roberts, J.M. Walshe, and D.W. Cox. 1995. The Wilson disease gene: spectrum of mutations and their consequences. Nat. Genet. 9:210-217.
14. Kato, J., Y. Kohgo, N. Sugawara, S. Katsuki, N. Shintani, K. Fujikawa, M. Kobune, N. Takeichi, and Y. Niitsu. 1993. Abnormal hepatic iron accumulation in LEC rats. Jpn. J. Cancer Res. 84:219-222.
15. Sugawara, N., T. Ikeda, C. Sugawara, Y. Kohgo, J. Kato, and N. Takeichi. 1992. Regional distribution of copper, xinc and iron in the brain in Long-Evans Cinnamon (LEC) rats with a new mutation causing hereditary hepatitis. Brain Res. 588:287-290.
16. Aust, S.D., L.A. Morehouse, and C.E. Thomas. 1985. Role of metals in oxygen radical reactions. J. Free Radical Biol. Med. 1:3-25.
17. Stohs, S.J., and D. Bagchi. 1995. Oxidative mechanisms in the toxicity of metal ions. J. Free Radical Biol. Med. 18:321-326.
18. Yamada, T., K. Sogawa, Y. Suzuki, K. Izumi, T. Agui, and K. Matsumoto. 1992. Elevation of the level of lipid peroxidation associated with hepatic injury in LEC mutant rat. Res. Comm. Chem. Pathol. Pharmacol. 77:121-124.
19. Berger, M., M. de Hazen, A. Nejjari, J. Fournier, J. Guignard, H. Pezerat, and J. Cadet. 1993. Radical oxidation reactions of the purine moiety of 2′-deoxyribonucleosides and DNA by iron-containing minerals. Carcinogenesis. 14:41-46.
20. Roche-Sicot, J., and J.-P. Benhamou. 1977. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann. Intern. Med. 86:301.
21. Robitallile, G.A., R.L. Piscatelli, E.J. Majeski, and T.D. Gelehrter. 1977. Hemolytic anemia in Wilson's disease. J. Am. Med. Assoc. 237:2402-2403.
22. Forman, S.J., K.S. Kumar, A.G. Redeker, and P. Hochstein. 1980. Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms. Am. J. Hematol. 9:269-275.
23. Deiss, A., G.R. Lee, and G.E. Cartwright. 1971. Hemolytic anemia in Wilson's disease. Ann. Intern. Med. 75:57-65.
24. Drysdale, J.W., and W.N.M. Ramsay. 1965. The separation of ferritin and haemosiderin for studies in the metabolism of iron. Biochem. J. 95:282-288.
25. Baliga, R., N. Ueda, and S.V. Shah. 1993. Increase in bleomycin-detectable iron in ischemia/reperfusion injury to rat kidneys. Biochem. J. 291:901-905.
26. International Committee for Standardization in Haematology. 1967. Recommendations for haemglometry in human blood. Br. J. Haematol. 13(Suppl.):71.
27. Yamanishi, H., S. Iyama, R. Fushimi, and N. Amino. 1996. Interference of ferritin in measurement of serum iron concentrations: comparison by five methods. Clin. Chem. 42:331-332.
28. Makino, T., and J.I. Itoh. 1981. A highly sensitive colorimetric determination of serum copper using alpha, beta, gamma, delta-tetrakis(4-N-trimethylaminophenyl)prophine. Clin. Chim. Acta. 111:1-8.
29. Gold, R., M. Schmied, G. Giegerich, H. Bretssschopf, H.P. Hartung, K.V. Toyka, and H. Lassmann. 1994. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71:219-225.
30. Sugawara, N., C. Sugawara, M. Sato, H. Takahashi, and M. Mori. 1992. Excessive accumulation of hepatic copper in LEC rats aged 80 days and 130 days with hepatitis. Pharmacol. Toxicol. 71:321-324.
31. Polterauer, P., R. Rauhs, and H. Puxkandl. 1981. Serum alpha-1-fetoprotein and serum lactate dehydrogenase isoenzymes in liver tumours. Wien. Klin. Wochenschr. 93:227-230.
32. Karin, M. 1985. Metallothioneins: proteins in search of function. Cell. 41:9-10.
33. Munro, H.N., and M.C. Linder. 1978. Ferritin: structure, biosynthesis and role in iron metabolism. Physiol Rev: 58:317-396.
34. Togashi, Y., Y. Li, J.-H. Kang, N. Takeichi, Y. Fujioka, K. Nagasawa, and H. Kobayashi. 1992. D-penicillamine prevents the development of hepatitis in Long-Evans cinnamon rats with abnormal copper metabolism. Hepatology. 15:82-87.
35. 2. Free Radical Res. Commun. 7:1-10.
36. Kanno, S., Y. Aoki, J.S. Suzuki, N. Takeichi, S. Misawa, and T. Suzuki. 1994. Enhanced synthesis of metallothionein as a possible cause of abnormal copper accumulation in LEC rats. J. Inorg. Biochem. 56:117-125.
37. Nakajima, M., J. Kato, Y. Kohgo, N. Takeichi, and Y. Niitsu. 1994. Point mutation of aldehyde dehydrogenase-2 gene in mutant strains of Long-Evans rats. Alcohol Alcohol. 29:39-43.